MY172685A - A lactobacillus crispatus and application thereof - Google Patents

A lactobacillus crispatus and application thereof

Info

Publication number
MY172685A
MY172685A MYPI2016000779A MYPI2016000779A MY172685A MY 172685 A MY172685 A MY 172685A MY PI2016000779 A MYPI2016000779 A MY PI2016000779A MY PI2016000779 A MYPI2016000779 A MY PI2016000779A MY 172685 A MY172685 A MY 172685A
Authority
MY
Malaysia
Prior art keywords
lactobacillus crispatus
application
lactobacillus
present
good
Prior art date
Application number
MYPI2016000779A
Other languages
English (en)
Inventor
Yang Liu
Original Assignee
Suzhou Osel Bio Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201310551630.3A external-priority patent/CN104630083B/zh
Priority claimed from CN201310731833.0A external-priority patent/CN104178437B/zh
Application filed by Suzhou Osel Bio Pharm Co Ltd filed Critical Suzhou Osel Bio Pharm Co Ltd
Publication of MY172685A publication Critical patent/MY172685A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MYPI2016000779A 2013-11-08 2014-10-30 A lactobacillus crispatus and application thereof MY172685A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201310551630.3A CN104630083B (zh) 2013-11-08 2013-11-08 一种卷曲乳杆菌及其在妇女保健产品中的应用
CN201310551661 2013-11-08
CN201310731833.0A CN104178437B (zh) 2013-11-08 2013-12-26 一种卷曲乳杆菌及其在妇科疾病中的应用

Publications (1)

Publication Number Publication Date
MY172685A true MY172685A (en) 2019-12-10

Family

ID=53040891

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2016000779A MY172685A (en) 2013-11-08 2014-10-30 A lactobacillus crispatus and application thereof

Country Status (9)

Country Link
US (1) US9937214B2 (enExample)
EP (1) EP3040413B1 (enExample)
JP (1) JP6890419B2 (enExample)
KR (1) KR101808972B1 (enExample)
ES (1) ES2670536T3 (enExample)
MY (1) MY172685A (enExample)
SG (1) SG11201603346VA (enExample)
TW (1) TWI652343B (enExample)
WO (1) WO2015067141A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018013583A2 (en) * 2016-07-11 2018-01-18 The Brigham And Women's Hospital, Inc. Medicinal vaginal lactobacillus cocktail
CN109874329B (zh) * 2016-08-12 2023-08-29 深圳华大生命科学研究院 一种产丁酸栖粪杆菌及其培养方法和应用
WO2019010282A1 (en) * 2017-07-07 2019-01-10 Osel, Inc. STABILIZED FORMULATIONS WITH HIGH POWER OF LACTOBACILLUS VAGINAL
AU2018298116A1 (en) * 2017-07-07 2020-02-27 Aarhus Universitet Use of vaginal lactobacilli for improving the success rate of in vitro fertilization
EP3427745A1 (en) 2017-07-12 2019-01-16 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO New probiotic composition for prevention of bacterial vaginosis
WO2019068862A1 (en) 2017-10-06 2019-04-11 Gedea Biotech Ab GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND / OR PREVENTION OF MICROBIAL INFECTIONS
AU2019274350B2 (en) * 2018-05-23 2022-04-07 Kobiolabs, Inc. Lactobacillus crispatus KBL693 strain and use thereof
GB201816425D0 (en) * 2018-10-09 2018-11-28 Tervisetehnoloogiate Arenduskeskus As Probiotics
CN109394796A (zh) * 2018-12-06 2019-03-01 青岛东海药业有限公司 卷曲乳杆菌制剂及其应用
CN112458007A (zh) * 2020-11-10 2021-03-09 深圳华大生命科学研究院 用于预防和/或治疗生殖道菌群紊乱相关疾病的卷曲乳杆菌
FR3117340B1 (fr) * 2020-12-15 2024-01-05 Basf Beauty Care Solutions France Sas Utilisation cosmétique, nutraceutique ou dermatologique d’une souche deLactobacillus crispatus et / ou d’une composition la comprenant
CN112708578A (zh) * 2020-12-31 2021-04-27 四川厌氧生物科技有限责任公司 一种卷曲乳杆菌及其应用
EP4274590A1 (en) * 2021-01-05 2023-11-15 Lactobio A/S Strains, compositions and methods of use
CN112899182B (zh) * 2021-01-08 2023-03-24 安徽省肿瘤医院 一种能够预防和/或治疗子宫颈鳞癌的卷曲乳杆菌
CN113512509B (zh) * 2021-05-07 2022-02-22 南方医科大学珠江医院 卷曲乳杆菌及其用途
KR102618322B1 (ko) * 2021-10-08 2023-12-27 순천향대학교 산학협력단 신규한 락토 바실러스 균주, 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
CN114214256B (zh) * 2022-01-12 2022-06-28 哈尔滨美华生物技术股份有限公司 一株用于防治泌尿生殖感染的格氏乳杆菌及其应用
CN114657093B (zh) * 2022-03-07 2023-07-07 北京市农林科学院 一株鸽源卷曲乳杆菌bl4014及其应用
CN116814474B (zh) * 2022-05-19 2025-07-04 广东君薇生物科技有限公司 一株卷曲乳杆菌及其应用
CN115404185A (zh) * 2022-08-31 2022-11-29 江苏新申奥生物科技有限公司 一种拮抗白色念珠菌的卷曲乳杆菌lcp051及其应用
CN116024129B (zh) * 2022-11-29 2024-09-24 光明乳业股份有限公司 一株能够与幽门螺杆菌共聚集的卷曲乳杆菌及其应用
CN116694498B (zh) * 2023-01-31 2026-02-24 江南大学 一种缓解多种阴道炎的阴道益生菌组合物
CN116286484B (zh) * 2023-02-08 2025-01-24 善恩康生物科技（苏州）有限公司 卷曲乳杆菌及其用途
KR20260006643A (ko) * 2023-06-20 2026-01-13 토요 슈가 리파이닝 컴퍼니 리미티드 세균의 증식 억제제, 그것을 포함하는 화장품, 의약 부외품 및 의약 조성물, 그리고 세균의 증식 억제 방법
CN116769676B (zh) * 2023-08-09 2023-12-05 杭州微致生物科技有限公司 一种卷曲乳杆菌及其应用
CN120330074A (zh) * 2024-01-17 2025-07-18 杭州远大生物制药有限公司 卷曲乳杆菌及其用途
WO2025207473A1 (en) * 2024-03-26 2025-10-02 Medstar Health, Inc. Methods and compositions for diagnosing and selectively treating or preventing urinary tract infection and urobiome dysbiosis
CN118256405B (zh) * 2024-05-31 2024-08-13 哈尔滨医科大学 卷曲乳杆菌fy121及其胞外囊泡在防治hpv感染及宫颈癌的应用
WO2025261345A1 (zh) * 2024-06-17 2025-12-26 上海赛增医疗科技有限公司 新型乳杆菌菌株及其组合物和应用
CN119506125A (zh) * 2024-10-24 2025-02-25 北京科拓恒通生物技术股份有限公司 一种可促进女性生殖道健康和延缓生殖道免疫衰老的卷曲乳杆菌
CN119326803B (zh) * 2024-12-19 2025-06-27 江西益百润生物科技有限公司 一种后生元组合物的制备方法及其产品和应用
CN120648589B (zh) * 2025-05-23 2026-06-26 乾生(宁波)科技有限公司 一种改善细菌性阴道炎的益生菌及其组合物和应用
CN120775750A (zh) * 2025-09-09 2025-10-14 成都大学 一种卷曲乳杆菌及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US8329447B2 (en) * 2008-12-12 2012-12-11 Osel, Inc. Strain of Lactobacillus crispatus
FR2992973B1 (fr) * 2012-07-09 2015-12-18 S P M D Nouvelle souche de lactobacillus crispatus
CN103074270A (zh) * 2012-11-15 2013-05-01 上海交大昂立股份有限公司 一种卷曲乳杆菌及其应用
CN104630083B (zh) * 2013-11-08 2018-07-06 苏州欧赛微科生物医药科技有限公司 一种卷曲乳杆菌及其在妇女保健产品中的应用
CN104178437B (zh) * 2013-11-08 2016-08-24 苏州欧赛微科生物医药科技有限公司 一种卷曲乳杆菌及其在妇科疾病中的应用

Also Published As

Publication number Publication date
EP3040413B1 (en) 2018-03-21
TW201531560A (zh) 2015-08-16
US20170020934A1 (en) 2017-01-26
SG11201603346VA (en) 2016-05-30
KR101808972B1 (ko) 2017-12-13
TWI652343B (zh) 2019-03-01
WO2015067141A1 (zh) 2015-05-14
JP2017501741A (ja) 2017-01-19
JP6890419B2 (ja) 2021-06-18
ES2670536T3 (es) 2018-05-30
US9937214B2 (en) 2018-04-10
EP3040413A4 (en) 2016-07-06
EP3040413A1 (en) 2016-07-06
KR20160067893A (ko) 2016-06-14

Similar Documents

Publication Publication Date Title
SanMiguel et al. Interactions between host factors and the skin microbiome
NZ630117A (en) Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
Hooven et al. Retrocyclin inhibits Gardnerella vaginalis biofilm formation and toxin activity
RU2010142489A (ru) Штамм lactobacillus rhamnosus
SE0402406D0 (sv) Probiotic lactobacillus strains for improved vaginal health
MY186323A (en) Lactobacillus salivarius for the treatment of mastitis
RU2015103116A (ru) Новый штамм lactobacillus crispatus
WO2015112980A3 (en) Dermaseptin-type and piscidin-type antimicrobial peptides
UA107095C2 (uk) Антибіотичні мікрочастинки для інгаляції
CN104382685A (zh) 一种人体阴道微生态制剂-益生菌避孕套的制备方法
TR201904382T4 (tr) Vajinit tedavisi.
CN116622570A (zh) 一种罗伊氏乳杆菌lr08及其制备防治阴道炎药物的用途、产品及方法
UA101873C2 (ru) Способ получения микробного органоминерального удобрения со свойствами иммуномодулятора, имеющего лечебный эффект при поражении растений бактериальными болезнями
KR20150075447A (ko) 여성 자궁 질염 예방 및 개선 기능성 조성물
TW201316996A (zh) 抑制陰道炎病原菌之乳酸桿菌及其用途
CN104170831A (zh) 一种杀虫剂
CN103006689A (zh) 止痒组合物及其在制备止痒剂中的应用
PH12013501765B1 (en) Sporulation-deficient b. texasporus cells and methods for efficient and cost-effective inactivation and use thereof
Alizadeh et al. Antibacterial activity of lactobacillus isolated from Iranian traditional sourdough on methicillin resistant staphylococcus aureus, Kelebciella pneumonia and Pseudomonas aeruginosa
Bukharin et al. Role of dominant microflora in mechanisms of woman vaginal biotope protection
김연숙 Identification of a Bacterial Strain, Bacillus Subtilis, Causative for Sialolithiasis and its Increased Adherence on Hydroxyapatite
UA114350C2 (uk) Штам бактерій lactobacillus delbrueckii для оброблення бджолиного пилку
WO2012099507A8 (ru) Биопрепарат балис для профилактики и лечения инфекционных болезней
RU2012146498A (ru) Способ профилактики послеродового эндометрита у крупного рогатого скота
BR112015032351A2 (pt) composição compreendendo l. rhamnosus gg